Business Daily from THE HINDU group of publications
Tuesday, Aug 04, 2009
ePaper | Mobile/PDA Version | Audio | Blogs
News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

 Corporate - Financial Performance
Corporate Results - Pharmaceuticals
Celestial Lab posts flat net

Hyderabad, Aug 3

Celestial Labs Ltd's net profit marginally increased to Rs 2.80 crore in the first quarter ended June 30, 2009 compared with Rs 2.72 crore in the corresponding quarter of previous financial year. Its total revenue increased 18 per cent at Rs 6.23 crore (Rs 5.24 crore). The earnings per share stood at Rs 2.50 (Rs 2.43). The board of directors recommended a final dividend of Re 0.50 a share (5 per cent on an equity share par value of Rs 10 each), the company informed the BSE. - Our Bureau

More Stories on : Financial Performance | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
SQL Star pref share allotment

Govt will protect its right to use, allocate gas: Deora
L&T hits Rs 5,300-cr ONGC gusher
Companies Bill, 2009 introduced in LS
Celestial Lab posts flat net
Higher tax provisioning dents Madhucon first quarter net
Rossell Tea posts two-fold rise in profit
Jayshree Chem proposes Rs 150-cr expansion
Emami Biotech plans Rs 400-cr project in Ethiopia
Polymed gets US nod for 6 products
‘RIL-RNRL gas deal is not a private arrangement’
Efforts on to reopen SPIC unit, says Azhagiri
SAIL production rises in July
‘Nano’ fever grips Tata cos
Mercedes sees better sales volume in second half
Indian Hotels may explore new debt servicing options
Mahindra looking to expand non-tractor farm equipment biz
Tata Motors revs up in July
India Cements’ sales rise 20% in July


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2009, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line